Board Appointments

By

Regulatory News | 11 Sep, 2019

Updated : 09:31

RNS Number : 9512L
Frontier Smart Technologies Grp Ltd
11 September 2019
 

11 September 2019

Frontier Smart Technologies Group Ltd

('Frontier' or the 'Company')

Board Appointments

Following the announcements on 21 August regarding Board Transition, Refinancing and Strategy, and 9 September confirming that the Company had reached an agreement with Science Group Plc ("Science Group") with regards to a Statutory Merger, the Company confirms that Martyn Ratcliffe, chairman of Science Group, and Sarah Cole, company secretary and group legal counsel of Science Group, have joined the board of Frontier as chairman and director respectively.

The following information is provided pursuant to Schedule 2(g) of the AIM Rules.

Martyn Roy Ratcliffe, 58, currently holds, or within the past 5 years has held, the following directorships and/or partnerships:

Current Directorships / Partnerships

Previous Directorships / Partnerships

Science Group Plc

Microgen Plc

 

Sarah Elizabeth Cole, 40, currently holds, or within the past 5 years has held, the following directorships and/or partnerships:

Current Directorships / Partnerships

Previous Directorships / Partnerships

Sagentia Technology Advisory Limited

In-reach UK Limited

Quadro Epsom Limited


OTM Consulting Limited


Sagentia Limited


Oakland Innovation Limited

Leatherhead Research Limited


Technology Sciences Group Consulting Limited


Technology Sciences Group Limited


SG Bidco Limited


Manage5nines Limited


TSGE Forum Limited


 

- Ends -

For Further Enquiries:

Frontier Smart Technologies Group Limited

+44 (0) 20 7391 0630

Anthony Sethill, Chief Executive Officer


Jonathan Apps, Chief Financial Officer




N+1 Singer (Nominated Adviser and Broker)

+44 (0) 20 7496 3000

Sandy Fraser / Lauren Kettle / Ben Farrow


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAGMGMLRMMGLZG

Last news